To elucidate the functional implications of MZT2B in NSCLC, we initiated our investigation by scrutinizing the impact of MZT2B transcriptional attenuation within the primary NSCLC cells (pNSCLC1, [17–21]). The gene discussed is MZT2B; the disease is non-small cell lung carcinoma.